CDKN2A and melanoma: Additionally, families with a strong predisposition to melanoma often carry pathogenic variants in the high-risk susceptibility genes CDKN2A and CDK4 that play pivotal roles in the cell cycle regulatory cascade governed by the RB1 pathway; this overlap suggests a biologically plausible link between RB1 dysfunction and an elevated risk for melanoma [6].